Eric K. Rowinsky
2013
In 2013, Eric K. Rowinsky earned a total compensation of $2.9M as Former Executive Vice President, Chief Medical Officer and Head of Research and Development at Stemline Therapeutics, a 152% increase compared to previous year.
Compensation breakdown
| Bonus | $175,000 |
|---|---|
| Non-Equity Incentive Plan | $277,500 |
| Salary | $341,663 |
| Stock Awards | $1,961,440 |
| Other | $191,592 |
| Total | $2,947,195 |
Rowinsky received $2M in stock awards, accounting for 67% of the total pay in 2013.
Rowinsky also received $175K in bonus, $277.5K in non-equity incentive plan, $341.7K in salary and $191.6K in other compensation.
Rankings
In 2013, Eric K. Rowinsky's compensation ranked 2,588th out of 12,286 executives tracked by ExecPay. In other words, Rowinsky earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,588 out of 12,286 | 79th |
Division Manufacturing | 855 out of 4,612 | 82nd |
Major group Chemicals And Allied Products | 228 out of 1,462 | 84th |
Industry group Drugs | 151 out of 1,156 | 87th |
Industry Pharmaceutical Preparations | 128 out of 890 | 86th |
Source: SEC filing on April 8, 2016.
Rowinsky's colleagues
We found four more compensation records of executives who worked with Eric K. Rowinsky at Stemline Therapeutics in 2013.